Camurus (NASDAQ STO: CAMX) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback